程嘉禾

摘要：目的 回顾性分析缩宫素联合卡前列素氨丁三醇治疗产后出血的临床作用机制。方法 对60例于2020年5月-2021年5月期间在我院分娩，且出现产后出血的产妇病例资料进行回顾性分析。并按照治疗方法将产妇资料分成2组进行治疗结果对比，A组为单一应用缩宫素治疗，B组为缩宫素联合卡前列素氨丁三醇治疗。结果 B组临床疗效高于A组，术后出血量及止血时间均少于A组，对比有统计学意义（P〈0.05）。结论 将缩宫素与卡前列素氨丁三醇共同应用到产后出血的治疗中，可加快产后止血速度，并降低产后出血量。

关键词：回顾性分析;缩宫素;卡前列素氨丁三醇;产后出血;作用机制

[Abstract] Objective To retrospectively analyze the clinical mechanism of oxytocin combined with carboprost and tromethamine in the treatment of postpartum hemorrhage. Methods the data of 60 pregnant women who gave birth in our hospital from May 2020 to may 2021 and had postpartum hemorrhage were analyzed retrospectively. According to the treatment methods，the maternal data were divided into two groups for comparison of treatment results. Group A was treated with oxytocin alone，and group B was treated with oxytocin combined with carboprost aminobutyric triol. Results the clinical efficacy of group B was higher than that of group A，and the amount of postoperative bleeding and hemostasis time were less than those of group A（P. Conclusion the combined application of oxytocin and carboprost tromethamine in the treatment of postpartum hemorrhage can accelerate the rate of postpartum hemostasis and reduce the amount of postpartum hemorrhage.

[Key words] Retrospective analysis;Oxytocin;Carboprost aminobutanol;Postpartum hemorrhage;Action mechanism

产后出血可出现休克、冒冷汗、血压下降、脉搏增快、手脚冰凉等临床表现，且属于引起孕产妇死亡的第一原因【1】。针对产后出血需要针对病因迅速止血，并补充血容量，同时纠正休克及预防感染【2】。而本次主要就缩宫素与卡前列素氨丁三醇的治疗效果展开研究，以期待提升我院产后出血救治成功率及有效率，并最终惠及广大产后出血产妇。现做如下报告：

1 资料和方法

1.1一般资料

对60例于2020年5月-2021年5月期间在我院分娩，且出现产后出血的产妇病例资料进行回顾性分析。并按照治疗方法将产妇资料分成2组，所有产妇均为单胎妊娠。A组年龄23-34岁，均值（29.15±2.37）岁;孕周37-41周，均值（39.51±0.80）周。B组年龄22-34岁，均值（29.11±2.29）岁;孕周38-41周，均值（39.92±0.91）周。对比产妇一般资料差异无统计学意义（P>0.05）。

1.2 治療方法

所有产妇均在胎儿娩出后在子……